Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAeorema Comm. Regulatory News (AEO)

Share Price Information for Aeorema Comm. (AEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 60.00
Bid: 58.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.897%)
Open: 60.00
High: 60.00
Low: 60.00
Prev. Close: 60.00
AEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options to Directors

17 Nov 2017 16:40

RNS Number : 8855W
Aeorema Communications Plc
17 November 2017
 

17 November 2017

 

Aeorema Communications plc ("Aeorema" or "the Company") 

 

Grant of Options to Directors

 

Aeorema Communications plc, the AIM-traded multi-media specialist, announces that on the 17 November 2017 it granted a total of 600,000 options to directors of the Company as follows:

 

Name

Title

Number of Options granted

Total options held following grant

Steve Quah

Joint Managing Director

300,000

600,000

Andrew Harvey

Joint Managing Director

300,000

300,000

 

The options have an exercise price of 29p. The options vest immediately and can be exercised in the period from the third anniversary of the date of grant until the tenth anniversary of the date of grant.

 

** ENDS **

For further information visit www.aeorema.com or contact:

 

Mike Hale

Aeorema Communications plc

Tel: +44 (0) 20 7291 0444

Marc Milmo / Catherine Leftley

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 7894 7000

Jeremy Porter / John Depasquale / Liz Kirchner

Allenby Capital Limited

(Joint Broker)

Tel: +44 (0)20 3328 5656

Isabel de Salis / Charlotte Page

St Brides Partners Ltd

(Financial PR)

Tel: +44 (0) 20 7236 1177

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Steve Quah

2

Reason for notification

 

 

 

a.

Position/Status

Joint Managing Director

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Aeorema Communications plc

b.

LEI

213800PJBW6O7NDCKJ08

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Options over Ordinary Shares of 12.5p each 

ISIN: GB00B4QHH456

b.

Nature of the transaction

Grant of options under the EMI Share Scheme

c.

Price(s) and volume(s)

Option awarded over 300,000 shares at an exercise price of 29p per share

 

d.

Aggregated information

- Aggregated Volume

- Price

N/A - Single Transaction

e.

Date of the transaction

17/11/17

f.

Place of the transaction

Outside of trading venue

 

 

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Andrew Harvey

2

Reason for notification

 

 

 

a.

Position/Status

Joint Managing Director

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Aeorema Communications plc

b.

LEI

213800PJBW6O7NDCKJ08

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Options over Ordinary Shares of 12.5p each 

ISIN: GB00B4QHH456

b.

Nature of the transaction

Grant of options under the EMI Share Scheme

c.

Price(s) and volume(s)

Option awarded over 300,000 shares at an exercise price of 29p per share

 

d.

Aggregated information

- Aggregated Volume

- Price

N/A - Single Transaction

e.

Date of the transaction

17/11/17

f.

Place of the transaction

Outside of trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBLBDBLDBBGRR
Date   Source Headline
12th Apr 20247:00 amRNSInvestor Presentation
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSDirectors’ Dealing
27th Mar 20242:54 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSInterim Results and FY Projections
5th Mar 20247:00 amRNSAgency Winners Of Creative Team Of The Year Award
6th Feb 20242:12 pmRNSHolding(s) in Company
14th Dec 202312:00 pmRNSResult of AGM
29th Nov 20237:00 amRNSCheerful Twentyfirst Wins Leading Industry Award
24th Nov 20237:00 amRNSPresenting at MelloLondon Investor Conference
23rd Nov 20237:00 amRNSNotice of Investor Presentation
20th Nov 20237:00 amRNSNotice of AGM and Posting of Annual Report
14th Nov 20237:00 amRNSFinal Results
11th Oct 20239:00 amRNSGrant of Options
18th Sep 20237:00 amRNSPresenting at MelloMonday Investor Event
26th Jul 20239:46 amRNSCheerful Twentyfirst Appoints US President
25th Jul 20237:00 amRNSTrading Update: Strong revenue & profit growth
21st Jul 202312:00 pmRNSInvestor Presentation
21st Jul 202310:00 amRNSHolding(s) in Company
17th Jul 20237:00 amRNSCheerful Twentyfirst Wins Multiple Industry Awards
28th Jun 20237:00 amRNSEventful Update – Promotion to Managing Director
3rd May 202310:06 amRNSHolding(s) in Company
18th Apr 20239:27 amRNSHolding(s) in Company
17th Apr 20233:04 pmRNSDirectors' Dealings
13th Apr 20237:00 amRNSDirectors’ Dealings
11th Apr 20231:12 pmRNSResult Of General Meeting
6th Apr 20234:15 pmRNSDirectors Shareholding - Replacement
6th Apr 20232:48 pmRNSDirector Shareholding
6th Apr 202310:03 amRNSHolding(s) in Company
29th Mar 20233:00 pmRNSInterim Results - Replacement
29th Mar 20237:00 amRNSInterim Results
21st Mar 20237:00 amRNSNotice Of General Meeting
13th Mar 20237:00 amRNSAgency Winners Of Creative Team of the Year
3rd Mar 202312:23 pmRNSHolding(s) in Company
1st Mar 20231:25 pmRNSTrading Update - Double Digit Revenue Growth
15th Feb 20232:13 pmRNSHolding(s) in Company
19th Jan 20232:17 pmRNSMajor Contract - Stagwell Cannes Lions Partnership
30th Dec 20221:00 pmRNSTotal Voting Rights
16th Dec 20224:34 pmRNSExercise of Options
15th Dec 202212:19 pmRNSResult of AGM
21st Nov 20227:00 amRNSNotice of AGM and Posting of Annual Report
14th Nov 20227:00 amRNSFinal Results
21st Oct 20227:00 amRNSGrant of Options
18th Aug 20227:00 amRNSTrading Update & Amsterdam Office
15th Jul 202210:30 amRNSHolding(s) in Company
13th Jul 20227:00 amRNSTrading Update - Strongest Year on Record
12th Jul 202210:43 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSAgency Winners for Creative Team of the Year

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.